-
Eurand Inc et al v. Anchen Pharmaceuticals Inc et al DC CAFC
- 1:09-cv-00923
- D. Del.
- Judge: Sue L. Robinson
- Filed: 12/08/2009
- Closed: 05/12/2011
- Latest Docket Entry: 12/02/2014
- PACER
- Docket updated daily
2
Plaintiffs
2
Defendants
1
Accused
Product
1
Patent-in-Suit
596
Days in
Litigation
-
Eurand Inc et al v. Anchen Pharmaceuticals Inc et al DC CAFC
- 1:09-cv-00923
- D. Del.
- Judge: Sue L. Robinson
- Filed: 12/08/2009
- Closed: 05/12/2011
- Latest Docket Entry: 12/02/2014
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim | Outcome |
|---|---|
| All challenged claims |
Invalid
Entry 42 |
-
Infringement
Anchen Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic AMRIX | US 7,544,372 B2 | All Asserted Claims |
No infringement
Entry 42
|
Anchen Pharmaceuticals
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic AMRIX | US 7,544,372 B2 | All Asserted Claims |
No infringement
Entry 42
|
Barr Laboratories Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic AMRIX | US 7,544,372 B2 | All Asserted Claims |
Infringement
Entry 42
|
Mylan Pharmaceuticals Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic AMRIX | US 7,544,372 B2 | All Asserted Claims |
Infringement
Entry 42
|
